Related Experiment Video
Updated: Mar 18, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
1.0K
Early salvage radiation therapy post-prostatectomy: key considerations.
Alessandro Morlacco1, R Jeffrey Karnes1
1Department of Urology, Mayo Clinic, Rochester, MN, USA.
Future Oncology (London, England)
|July 9, 2016
Summary
Observation and early salvage radiotherapy (SRT) show promise after prostatectomy, potentially offering a suitable alternative to adjuvant radiotherapy. Patient selection, optimal SRT parameters, and hormonal therapy require further investigation for improved outcomes.
Area of Science:
- Urology
- Radiation Oncology
- Oncology
Background:
- Post-prostatectomy radiotherapy (RT) is used as adjuvant RT for adverse features or salvage RT (SRT) for recurrence.
- Direct comparisons between adjuvant RT and SRT are lacking.
- Retrospective data suggest observation and early SRT (eSRT) may be a viable option.
Purpose of the Study:
- To review the current literature on early salvage radiotherapy (eSRT) after prostatectomy.
- To discuss patient selection strategies for eSRT.
- To highlight ongoing questions and future directions in eSRT.
Main Methods:
- Literature review of current studies on eSRT.
- Analysis of clinical and biomarker-based tools for patient selection.
- Discussion of unresolved issues regarding eSRT parameters.
Main Results:
- Growing retrospective evidence supports the efficacy of observation and eSRT.
- Patient selection is critical for successful eSRT.
- Optimal thresholds for prostate-specific antigen, RT dose, field, and hormonal therapy remain under investigation.
Conclusions:
- Early salvage radiotherapy (eSRT) is a potentially effective strategy post-prostatectomy.
- Further research is needed to refine patient selection and optimize eSRT protocols.
- Future studies will likely focus on personalized approaches to eSRT.
